ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 19.43 Delayed Data As of Mar 21 |  -0.33 / -1.67%Today’s Change | 12.24 Today|||52-Week Range 28.06 | +22.05% Year-to-Date |
Latest ACAD News | Press Releases
| Biotech Stock Roundup: ACAD's Drug Approval, SGEN to be Acquired by PFE & More Mar 16 / Zacks.com - Paid Partner Content | 3 Nasdaq Stocks on Watch This Week Mar 12 / MotleyFool.com - Paid Partner Content |
| Strength Seen in Acadia (ACAD): Can Its 5.0% Jump Turn into More Strength? Mar 15 / Zacks.com - Paid Partner Content | BioNTech (BNTX) to Report Q4 Earnings: What's in the Cards? Mar 10 / Zacks.com - Paid Partner Content |
| Acadia (ACAD) Gets FDA Approval for Daybue for Rett Syndrome Mar 13 / Zacks.com - Paid Partner Content |
